#00370
Waste from pharmaceutical manufacturing, healthcare, households, farms and sewage systems releases antibiotics, resistant bacteria and resistance genes into environmental reservoirs.
Set enforceable antibiotic-residue limits for manufacturing wastewater and solid waste, require monitoring and audits, and make compliance part of procurement and regulatory approval.
Use ozonation, activated carbon, advanced oxidation, membranes, or source-specific pretreatment at high-risk facilities after effective conventional treatment, with monitoring of antibiotic residues, resistant bacteria, resistance genes, and treatment by-products.
Keep unused medicines, contaminated manure, healthcare waste and treatment sludge out of uncontrolled drains, fields and dumps through collection, treatment and risk-based reuse rules.